ARCHIVES

FDA Advisors Unanimously Turn Down GPC Biotech’s Orplatna for Prostate Cancer.

This article is from The Cancer Letter archive.

Vol. 33 No. 29 | July 27, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: Reagan Okays Reauthorization; Harold Freeman ACS President, Robert Schweitzer President Elect

November 11, 1988

Duke Promised $11.5M For Eye, Lung Research.

March 8, 2002

House Disallows NCI Recision

March 14, 1975

NCI audit Verifies Accuracy Of NSABP’s Lumpectomy Trial, B-06; Finds No Evidence Of Misrepresentation

October 21, 1994

ASCO Updates Guideline On Follow-Up Management

October 27, 2006

In Brief: General Motors Cancer Prizes Awarded; Thomas Promoted; HIV Research funding

June 24, 1994